Mayne Pharma Acquires 42 Generic Drugs

mayne pharma

Mayne Pharma has acquired 42 generic drugs from Teva and Allergan for about $652 million. The acquisition will help Mayne Pharma expand into the US market. Teva and Allergan have been selling off generic products in order to meet certain antitrust requirements for the sale of Allergan’s generics business to Teva to go through. Once finalized, Mayne Pharma’s acquisition will make the company a top 25 player in the US retail generics market.

Read the source article at Pharma Live

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>